drugset / Trial / NCT00393198

Bleeding Pattern and User Satisfaction During Second Consecutive MIRENA® in Contraception and Treatment of Menorrhagia

NCT00393198

Phase 4 Completed 204 enrolled Bayer
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the bleeding pattern during the last 3 months of the first MIRENA® and the first year of the second MIRENA® use.

Timeline

Start
2006-10
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Levonorgestrel Small molecule 20 ug Other
Comparator Misoprostol Other / unclassified 400 ug Subcutaneous

Indications